The Nutshell

» funding, NIH and disease/medicine

Daily News Roundup

Most Recent

image: CRISPR Therapy to Enter Trials

CRISPR Therapy to Enter Trials

By | July 25, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

0 Comments

image: GM Mosquitoes Reduce Dengue Cases in Brazil

GM Mosquitoes Reduce Dengue Cases in Brazil

By | July 18, 2016

Field data from the biotech company Oxitec show that releasing genetically modified male mosquitoes whose offspring die helped reduce dengue cases by 90 percent in one year.

2 Comments

image: Open Letter Leads to Peer Review Changes

Open Letter Leads to Peer Review Changes

By | July 14, 2016

The Canadian Institutes of Health Research will reverse some of the recent changes to its grant-reviewing processes after protests from researchers.

0 Comments

Nearly 1,200 scientists are asking the Canadian Institutes of Health Research to undo recent changes to its grant-review process.

0 Comments

image: Treating Cancer with CRISPR?

Treating Cancer with CRISPR?

By | June 17, 2016

A federal panel will review the first proposal for the use of the technology to edit human genes for medical purposes.

0 Comments

image: Mapping Zoonotic Disease

Mapping Zoonotic Disease

By | June 14, 2016

Researchers aim to predict new infectious disease outbreaks that spread from animals to humans.

0 Comments

image: Altered Sense of Touch in Autism?

Altered Sense of Touch in Autism?

By | June 10, 2016

A mouse study suggests that disruptions to nerves in the skin may contribute to autism spectrum disorder.

1 Comment

Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.

0 Comments

A Congressional investigation indicates that the National Football League may have sought to steer millions of dollars in National Institutes of Health funding away from one of its critics.

0 Comments

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

The US Food and Drug Administration greenlights Roche’s Tecentriq, which blocks a protein that obstructs the immune system’s ability to fight cancer.

0 Comments

Popular Now

  1. Mapping the Human Connectome
    Daily News Mapping the Human Connectome

    A new map of human cortex combines data from multiple imaging modalities and comprises 180 distinct regions.

  2. Will Organs-in-a-Dish Ever Replace Animal Models?
  3. Your Office Has a Distinct Microbiome
  4. Neurons Compete to Form Memories
RayBiotech